CHCWM – Cancer & Hematology Centers of West Michigan

XL092 (Exelixis)

A Dose-Escalation and Expansion Study of the Safety and Pharmacokinetics of XL092 in Subjects with Inoperable Locally Advanced or Metastatic Solid Tumors